These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 1714949

  • 1. A loading dose/continuous infusion schedule of fludarabine phosphate in chronic lymphocytic leukemia.
    Puccio CA, Mittelman A, Lichtman SM, Silver RT, Budman DR, Ahmed T, Feldman EJ, Coleman M, Arnold PM, Arlin ZA.
    J Clin Oncol; 1991 Sep; 9(9):1562-9. PubMed ID: 1714949
    [Abstract] [Full Text] [Related]

  • 2. [Phase II clinical study of SH L 573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia].
    Miyawaki S, Imamura M, Kobayashi S, Ohnishi K, Hodohara K, Mizoguchi H, Tomonaga M, Tango T, Ohno R.
    Rinsho Ketsueki; 1999 Dec; 40(12):1236-44. PubMed ID: 10658476
    [Abstract] [Full Text] [Related]

  • 3. Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up report.
    Sorensen JM, Vena DA, Fallavollita A, Chun HG, Cheson BD.
    J Clin Oncol; 1997 Feb; 15(2):458-65. PubMed ID: 9053466
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemia.
    Boogaerts MA, Van Hoof A, Catovsky D, Kovacs M, Montillo M, Zinzani PL, Binet JL, Feremans W, Marcus R, Bosch F, Verhoef G, Klein M.
    J Clin Oncol; 2001 Nov 15; 19(22):4252-8. PubMed ID: 11709569
    [Abstract] [Full Text] [Related]

  • 6. Fludarabine monophosphate as salvage for refractory chronic lymphocytic leukaemia.
    Pillay GS, Wood L, Jacobs P.
    S Afr Med J; 1996 Aug 15; 86(8):949-51. PubMed ID: 8823419
    [Abstract] [Full Text] [Related]

  • 7. Fludarabine: a new agent with major activity against chronic lymphocytic leukemia.
    Keating MJ, Kantarjian H, Talpaz M, Redman J, Koller C, Barlogie B, Velasquez W, Plunkett W, Freireich EJ, McCredie KB.
    Blood; 1989 Jul 15; 74(1):19-25. PubMed ID: 2473795
    [Abstract] [Full Text] [Related]

  • 8. Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia.
    Grever MR, Kopecky KJ, Coltman CA, Files JC, Greenberg BR, Hutton JJ, Talley R, Von Hoff DD, Balcerzak SP.
    Nouv Rev Fr Hematol (1978); 1988 Jul 15; 30(5-6):457-9. PubMed ID: 2464793
    [Abstract] [Full Text] [Related]

  • 9. Treatment of advanced chronic lymphocytic leukemia by fludarabine. Results of a clinical phase-II study.
    Hiddemann W, Rottmann R, Wörmann B, Thiel A, Essink M, Ottensmeier C, Freund M, Büchner T, van de Loo J.
    Ann Hematol; 1991 Jul 15; 63(1):1-4. PubMed ID: 1715191
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia.
    Rossi JF, van Hoof A, de Boeck K, Johnson SA, Bron D, Foussard C, Lister TA, Berthou C, Kramer MH, Littlewood TJ, Marcus RE, Deconinck E, Montillo M, Guibon O, Tollerfield SM.
    J Clin Oncol; 2004 Apr 01; 22(7):1260-7. PubMed ID: 15051774
    [Abstract] [Full Text] [Related]

  • 11. A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211.
    Byrd JC, Peterson B, Piro L, Saven A, Vardiman JW, Larson RA, Schiffer C.
    Leukemia; 2003 Feb 01; 17(2):323-7. PubMed ID: 12592330
    [Abstract] [Full Text] [Related]

  • 12. Fludarabine phosphate in the treatment of chronic lymphocytic leukemia.
    Keating MJ.
    Semin Oncol; 1990 Oct 01; 17(5 Suppl 8):49-62. PubMed ID: 1699283
    [Abstract] [Full Text] [Related]

  • 13. Phase I clinical investigation of fludarabine phosphate by a loading-dose and continuous-infusion schedule.
    Leiby JM, Grever MR, Staubus AE, Neidhart JA, Malspeis L.
    J Natl Cancer Inst; 1988 May 18; 80(6):447-9. PubMed ID: 2452888
    [Abstract] [Full Text] [Related]

  • 14. [Phase I clinical study of SH L573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia and adult T-cell leukemia/lymphoma].
    Arima N, Mizoguchi H, Shirakawa S, Tomonaga M, Takatsuki K, Ohno R.
    Gan To Kagaku Ryoho; 1999 Apr 18; 26(5):619-29. PubMed ID: 10234292
    [Abstract] [Full Text] [Related]

  • 15. A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic leukemia: a Southwest Oncology Group study.
    Elias L, Stock-Novack D, Head DR, Grever MR, Weick JK, Chapman RA, Godwin JE, Metz EN, Appelbaum FR.
    Leukemia; 1993 Mar 18; 7(3):361-5. PubMed ID: 7680398
    [Abstract] [Full Text] [Related]

  • 16. Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström's macroglobulinemia, and mantle-cell lymphoma.
    Foran JM, Rohatiner AZ, Coiffier B, Barbui T, Johnson SA, Hiddemann W, Radford JA, Norton AJ, Tollerfield SM, Wilson MP, Lister TA.
    J Clin Oncol; 1999 Feb 18; 17(2):546-53. PubMed ID: 10080598
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with "low-grade" non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia.
    Foran JM, Oscier D, Orchard J, Johnson SA, Tighe M, Cullen MH, de Takats PG, Kraus C, Klein M, Lister TA.
    J Clin Oncol; 1999 May 18; 17(5):1574-9. PubMed ID: 10334546
    [Abstract] [Full Text] [Related]

  • 18. Fludarabine monophosphate in refractory B-chronic lymphocytic leukemia: maintenance may be significant to sustain response.
    Angelopoulou MA, Poziopoulos C, Boussiotis VA, Kontopidou F, Pangalis GA.
    Leuk Lymphoma; 1996 Apr 18; 21(3-4):321-4. PubMed ID: 8726414
    [Abstract] [Full Text] [Related]

  • 19. [Fludarabine monophosphate in the treatment of patients with advanced stages of chronic B-cell lymphatic leukemia resistant to conventional chemotherapy].
    Papajík T, Faber E, Hubácek J, Slezák P, Raida L, Heczko M, Sulovská I, Jarosová M, Pikalová Z, Indrák K.
    Vnitr Lek; 1997 Jan 18; 43(1):25-8. PubMed ID: 9221561
    [Abstract] [Full Text] [Related]

  • 20. Autoimmune thrombocytopenia after six cycles of fludarabine phosphate in a patient with chronic lymphocytic leukemia.
    Bay JO, Fouassier M, Béal D, Alcaraz L, Cure H, Chollet P, Plagne R, Travade P.
    Hematol Cell Ther; 1997 Aug 18; 39(4):209-12. PubMed ID: 9352330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.